Fortress Biotech
FBIO
#9176
Rank
C$0.15 B
Marketcap
C$4.86
Share price
-4.53%
Change (1 day)
93.79%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2025 (TTM): -C$76.35 Million

According to Fortress Biotech 's latest financial reports the company's current earnings are C$62.3 Million. In 2024 the company made an earning of -C$0.17 Billion, an increase over its 2023 earnings that were of -C$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$76.35 Million-53.33%
2024 -C$0.17 Billion-21.6%
2023 -C$0.21 Billion-28.03%
2022 -C$0.29 Billion29.88%
2021 -C$0.23 Billion59.8%
2020 -C$0.14 Billion1.17%
2019 -C$0.14 Billion-19.84%
2018 -C$0.18 Billion28.99%
2017 -C$0.14 Billion37.92%
2016 -C$96.82 Million32.31%
2015 -C$73.18 Million164.31%
2014 -C$27.69 Million-45.14%
2013 -C$50.47 Million37.55%
2012 -C$36.69 Million-22.91%
2011 -C$47.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Veracyte
VCYT
C$33.6 M-146.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.16 Billion 120.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-C$46.21 Million-36.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-C$46.03 Million-36.62%๐Ÿ‡บ๐Ÿ‡ธ USA